Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-K, Date: 2017-02-23, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CBPO/20170223/10-K/1/000.htm SEC Original: v459520_10k.htm
Annual Report on Form 10-K Year Ended December 31, 2016 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data 50 Item 7. Management’s Discussion

---

---

Webplus: CBPO/20170223/10-K/2_EX-4.5/000.htm SEC Original: v459520_ex4-5.htm
Execution Version PREFERRED SHARES RIGHTS AGREEMENT Dated as of February 2 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION, TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 12 13 Section 6. Transfer, Split Up, Combination and Exchange of Rights

---

---

Webplus: CBPO/20170223/10-K/3_EX-21/000.htm SEC Original: v459520_ex21.htm
CHINA BIOLOGIC PRODUCTS, INC. The subsidiaries of China Biologic Products, Inc. are as follows: Jurisdiction of Name Incorporation or Organization Ownership Interest Taibang Biological Ltd. BVI 100.0% Taibang Holdings (Hong Kong) Limited HK 100.0% Taibang Biotech (Shandong) Co., Ltd. Shandong PRC 100.0% Taibang (Beijing) Pharmaceutical Research Institute Co., Ltd. Beijing PRC 100.0% Shandong Taibang Biological Products Co., Ltd. Shandong PRC

---

---

Webplus: CBPO/20170223/10-K/4_EX-23.1/000.htm SEC Original: v459520_ex23-1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statement (No. 333-204761) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated February 23, 2017, with respect to the consolidated balance sheets of China Biologic Products, Inc.

---

---

Webplus: CBPO/20170223/10-K/5_EX-31.1/000.htm SEC Original: v459520_ex31-1.htm
CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CBPO/20170223/10-K/6_EX-31.2/000.htm SEC Original: v459520_ex31-2.htm
CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CBPO/20170223/10-K/7_EX-32.1/000.htm SEC Original: v459520_ex32-1.htm
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. rd David (Xiaoying) Gao Chief Executive Officer

---

---

Webplus: CBPO/20170223/10-K/8_EX-32.2/000.htm SEC Original: v459520_ex32-2.htm
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. rd Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)

---

Company Info:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-K, Date: 2017-02-23, XBRL Interactive FinancialsCIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125